Distribution of Starry Pharmaceutical's revenue in 2022, by product type
In 2022, the Chinese pharmaceutical firm Starry Pharmaceutical gained revenue of 1.75 billion yuan from manufacturing contrast agent. Although a relatively small company in the industry, Starry is one of the most important manufacturers of radiocontrast agents in China.